China Biotech Services Holdings Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 623.76 million compared to HKD 655.79 million a year ago. Net income was HKD 19.39 million compared to HKD 30.17 million a year ago.

Basic earnings per share from continuing operations was HKD 0.02 compared to HKD 0.031 a year ago.